#Product Trends
100 Micro+ Smokerlyzer® CO monitors sold to the Indonesian Department of Health
In Indonesia, 67% of adult males and 41% of male youths smoke, while the figures for women are much lower at 2.7% for adult females and 6.2% for female youths. It is estimated that healthcare costs attributed to tobacco-related illness in Indonesia amount to $1.2 billion each year.*
The Micro+ Smokerlyzer measures the amount of carbon monoxide (CO) in exhaled breath and is Bedfont''s premium CO monitor. It is a longstanding benchmark device used in smoking cessation support, clinical trials and research.
Jason Smith, General Manager at Bedfont Scientific Ltd, said, “We are delighted to have the Indonesian Department of Health purchase our products and use them in this important work.
The 100 Micro+ Smokerlyzer units will be used by smoking cessation advisors to demonstrate the levels of CO in the blood of those who smoke, providing a motivational visual aid that can help them to give up smoking.”
